OrbusNeich Medical Group Holdings Limited, an investment holding company, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Shatin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.
OrbusNeich Medical Dividend Announcement
• OrbusNeich Medical announced a annually dividend of HK$0.10 per ordinary share which will be made payable on . Ex dividend date: 2024-06-11
• OrbusNeich Medical annual dividend for 2024 was HK$0.10
• OrbusNeich Medical's trailing twelve-month (TTM) dividend yield is 2.63%
• OrbusNeich Medical's payout ratio for the trailing twelve months (TTM) is 27.42%
OrbusNeich Medical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-11 | HK$0.10 | annually |
OrbusNeich Medical Dividend per year
OrbusNeich Medical Dividend Yield
OrbusNeich Medical current trailing twelve-month (TTM) dividend yield is 2.63%. Interested in purchasing OrbusNeich Medical stock? Use our calculator to estimate your expected dividend yield:
OrbusNeich Medical Financial Ratios
OrbusNeich Medical Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy OrbusNeich Medical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.